Additionally, given the inconsistencies between previous reports of CVD risk based on APOE status as well as the lack of long-term studies examining APOE-related T2DM incidence, our study offers a unique contribution to the literature. The gene discussed is APOE; the disease is type 2 diabetes mellitus.